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We first detected the mRNA expression of follistatin and three subunits of inhibimactivin m rat pancreatic islets by reverse transcription-polymerase 
chain reaction (RT-PCR). Immunohistochemistry using anti-follistatin serum (against residues 123-l 34) revealed that follistatin was localized only 
in insulin-producing B cells. Although the PA subunit was detectable in the islets, the immunostainable cell types were completely different with 
two PA antisera, i.e. anti-/IA (1-lO)-Tyr stained B cells, while anti-PA (87-99) stained glucagon-producing A cells. This inconsistent immunoreac- 
tivity was probably related to follistatin binding top subunits of inhibimactivin. This study indicates that follistatin and inhibimactivin in the islet 
serve as paracrine or autocrine modulators in the endocrine pancreas. 
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1. INTRODUCTION 
Inhibin and activin which were originally purified 
from gonads and believed to modulate FSH secretion 
from the pituitary gland [l-4], have potent activities in 
diverse biological systems uch as erythroid differentia- 
tion [5,6], mesoderm induction [7,8] and neural differen- 
tiation [9,10]. Follistatin, which binds to both inhibin 
and activin through the common /I subunit [ 11,121, neu- 
tralizes activin action in various systems and is thought 
to be a functional regulator of inhibin/activin [ll-141. 
These molecules are broadly distributed in the nervous 
and endocrine systems [15,16]. Although activin stimu- 
lates insulin secretion from isolated pancreatic islets in 
vitro [17], there is no evidence that these molecules are 
localized in the gastro-entero-pancreatic (GEP) endo- 
crine system. In the present study, we first detected the 
expression of ~1, /IA, and /?B subunits of inhibin/activin 
and follistatin mRNAs in rat pancreatic islets by reverse 
transcription polymerase chain reaction (RT-PCR). 
Furthermore, histochemical reaction to antisera raised 
against synthetic peptides confirmed the localization of 
inhibin/activin and follistatin in the islet of Langerhans. 
2. MATERIALS AND METHODS 
2.1. Animals and treatment 
Female Wistar Imamichi rats, 200-250 g, were obtained from The 
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Imamichi Institute for Animal Reproduction (Ibaraki, Japan). The 
animals were injected intravenously with a single dose of 65 mg/kg of 
streptozotocin (STZ; Wako Chemicals, Osaka, Japan) dissolved in 0.5 
ml of 0.1 M citrate buffer, pH 4.5. At 24 h after STZ injection, 
pancreata were excised from intact or STZ-treated rats. The excised 
pancreata were fixed in Bouin’s fixative by microwave treatment for 
20 s at 4°C and immersed in the same fixative for 4-6 h at room 
temperature. Fixed tissues were dehydrated in a graded ethanol series, 
cleared in xylene, and embedded in paraffin blocks. Sections were cut 
on a sliding microtome and then subjected to immunohistochemical 
procedures. 
Pancreatic islets were isolated from another group of animals by 
collagenase treatment [18]. These islets were subjected to acid gua- 
mdium thiocyanate-phenol-chloroform (AGPC) RNA extraction [19]. 
RNA was stored at -20°C until used. 
2.2. Preparation of antisera 
Antisera against follistatin or PA subunit of inhibin or activin were 
made in rabbits using synthetic peptides as immunogens. Anti-folhs- 
tatin antiserum was raised against human follistatin peptide (residues 
123-134) as previously described [20,21]. Two antisera against he/IA 
subunit of inhibimactivin were raised with two different synthetic 
peptides [22,23]. Anti-/IA (I-lO)-Tyr was raised against he N-terminal 
of /IA subunits. The other antiserum, anti-PA (87-99) was against 
amino acid residues 87-99 of PA. Guinea pig anti-insulin serum and 
rabbit anti-glucagon serum were obtained from Linco Research Inc. 
(St. Louis, MO). Rabbit anti-somatostatin-14 serum was purchased 
from Cambridge Research Biochemicals Ltd. (Wilmington, DE). 
2.3. Immunohistochemical procedure 
The avidin-biotin-peroxidase (ABC) procedure was performed as 
described previously [22]. To detect he cross reactivities of anti-follis- 
tatin, anti-/IA (I-10)-Tyr, and anti-/IA (87-99) to insulin or glucagon 
molecules, primary antisera were preincubated with 5 mg/ml of Insulin 
(Collaborative Research Inc., Bedford, MA) or 0.5 mg/ml of glucagon 
(Collaborative Research Inc., Bedford, MA) for 1 h at room temper- 
ature before applying them to the sections. A double-staining proce- 
dure was performed to identify the cell types which have follistatm- 
Volume 3 19. number 3 FEBS LETTERS March 1993 
or activin-like lmmunoreactivities in the islet of Langerhans. After 
treatment with primary antisera (anti-folhstatin, anti-DA (I-10)-Tyr, 
or anti-/IA (87?99)), the sections were incubated with rhodamine- 
labeled goat anti-rabbit IgG for 30 min. The specimens were observed 
with an Olympus BHK-RFK photomlcroscope equipped with epifluo- 
rescence optics. Then the sections were subjected to ABC procedures 
using anti-insulin. -glucagon. or -somatostatin antisera. 
2.4. RT-PCR and sequencrng 
cDNA was synthesized from total RNA of isolated islets by Super- 
Script Preamplification System (BRL, Gaithersburg. MD). To [den- 
tify follistatin and three subunits of inhibitiactivin proteins, several 
oligonucleotide primers corresponding to the amino acid sequence of 
those protein molecules were subjected to RT-PCR using mRNA 
obtained from rat pancreatic islets. The oligonucleotide primers were 
prepared according to the amino acid sequences of rat follistatin [16] 
or a, DA and ,!?B subunits of rat mhibin/activin [2] as follows, S- 
GGGCAGGATCCATTGGATTAGCCTAT-3’ and S-ACACTGC- 
TGGACAGTTTACCACTCT-3’ for follistatm, 5’-TTCATTTTCC- 
ACTACTGCCATGGTAGCT-3’ and S-GATACAAGCACAGTG- 
TTGTGTAATGAG-3’ for inhlbin a subunit, 5’-TCAACAGTCAT- 
TAACCACTACCGCATGA-3’ and S-AGCCACACTCCTCCA- 
CAATCATGTT-3’ for inhibin/actlvingA subunit, and Y-AGGCAA- 
CAGTTCTTCATCGACTTTCGGCT-3’ and 5’-AGCCACACTCC- 
TCCACAATCATGTT-3’ for mhibmlactivin /IB subunit. The reac- 
tion was cycled 3045 times with a cycle profile of 1 min at 94”C, I 
min at 55°C and 1.5 min at 72°C. Bands of corresponding size were 
cloned into pUC18 plasmid and sequenced by the Tuy method 
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Fig. 1. Detection of follistatin and a, PA and /?B subunits of inhibm/ 
actlvin mRNA in islet of Langerhans by RT-PCR. The follistatin 
products (expected size 370 bp) were generated from isolated islets 
(lane 1). The corresponding length of a (240 bp),BA (165 bp) and/IB 
(300 bp) cDNA products were cloned from isolated islets by RT-PCR 
(lanes 2-4). The cDNA sequence of each subunit and follistatin was 
identical to the corresponding region of rat mhibm. actlvin [2] and 
folhstatin [14]. respectively. 
3. RESULTS 
3.2. Histochemical locakation of immunoreactive DA 
subunit of inhibinlactivin and follistatin in islet of 
Langerhans 3.1. IdentiJication of a, /IA and /lB subunits of inhibinl 
activin and follistatin in islet of Langerhans The immunohistochemical reaction of islet cells with 
Expression of follistatin and three subunits of in- anti-follistatin antiserum is shown in Fig. 2. Cells lo- 
hibin/activin mRNAs were demonstrated in isolated cated widely in the islet of Langerhans exhibited intense 
pancreatic islets by RT-PCR. RT-PCR of islet RNA immunoreaction with anti-follistatin (Fig. 2A). These 
yielded a single band of cDNA corresponding to each cells were identified as insulin-producing pancreatic B 
protein fragment (Fig. 1). The cDNA sequence of each cells by double-staining the same section with anti-insu- 
molecule was identical to the corresponding region of lin antiserum (Fig. 2A,B). The intense reaction of B cells 
rat inhibin, activin and follistatin, respectively. with anti-follistatin could not be abolished by pread- 
Fig. 2. Histochemical micrographs showmg localization of immunoreactive folhstatin in rat pancreatic islets. (A) Fluorescence micrograph 
indicating the cells, round in shape, which are located centrally in the islet exhibit intense immunoreactlons with anti-follistatin. (B) The same section 
which is subjected to avidin-biotin-peroxidase stainig with anti-insulin antlserum showmg the cells stamed with anti-follistatin antiserum are 
identified with insulin-producing cells, pancreatic B cells. 
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Fig. 3. Histochemical localization of PA subunit in rat islet cells using two different antibodies. (A) Pancreatic B cells were stained with anti-PA 
(I-10)-Tyr as well as the reactions with anti-follistatin, however, immunoreactions with anti-PA (87-99) (B) were found in pancreatic A cells in 
contrast to anti-DA (I-10)-Tyr reactions. 
sorption of antiserum with 5 mg/ml of insulin, whereas 
anti-insulin reactions were completely eliminated. At 24 
h after STZ treatment, the majority of islet cells were 
glucagon-producing A cells and somatostatin-produc- 
ing D cells. Although immunoreactions with anti-insu- 
lin persisted in the few remaining B cells, follistatin- 
immunoreactivity completely disappeared in the same 
islets. 
Localization of immunoreactive /3A subunits of in- 
hibimactivin in the islet cells was demonstrated with two 
different antisera. Although the islet cells were stained 
with both antisera, the staining characteristics were re- 
markably different. Immunoreactions to both anti-/IA 
(1-10)-Tyr and anti-follistatin antisera were found in 
double-stained B cells (Fig. 3A). The reactions also were 
affected by STZ treatment. However, reactions to anti- 
/IA (87-99) were found only in glucagon producing pan- 
creatic A cells (Fig. 3B), while only B cells reacted with 
anti-/3A (1-10)-Tyr. The reaction in A cells was not 
affected by STZ treatment. Preadsorption with antise- 
rum containing 5 mg/ml of insulin or 0.5 mg/ml of glu- 
cagon did not interfere with these reactions. Somato- 
statin-producing D cells were not stained with any anti- 
sera used in this study. 
4. DISCUSSION 
The present study demonstrates for the first time that 
pancreatic islet cells are the site of inhibin, activin, and 
follistatin production. RT-PCR and immunohisto- 
chemistry results suggest that insulin producing B cells 
are the site of follistatin production. Detecting three 
subunits of inhibimactivin in pancreatic islets strongly 
suggests that islet cells secrete both inhibin and activin. 
Although immunoreactive PA subunits are localized in 
the islet of Langerhans, it is uncertain why the im- 
munostainable cells react differently with two types of 
anti-/IA antisera (Fig. 3A,B). One possible explanation 
of this inconsistency is that inhibimactivin in the B cells 
are bound to follistatin, and the altered /?A subunit 
conformation conceals the 87-99 amino acid region 
while revealing the N-terminal epitope. In contrast, in 
A cells where inhibimactivin are free from follistatin, 
the 87-99 amino acid residues are revealed while con- 
cealing the N-termini of their /3A subunits. Additional 
studies are needed to clarify the molecular state of in- 
hibin and activin in the individual type of islet cells. 
A major function of the islet of Langerhans is secre- 
tion of insulin and glucagon. The role of inhibimactivin 
and follistatin in the pancreatic islet is not clear. Since 
these molecules were initially isolated from gonads, they 
were thought to be a long-loop modulator of FSH secre- 
tion in the pituitary-gonadal axis. However, reports of 
localization and function in various physiological sys- 
tems [l-10,1 5,161 suggests that they act as a local regu- 
lator in an autocrine or paracrine manner rather than 
as a modulator in a long-loop fashion, The present 
study suggests that inhibin/activin and follistatin may 
play a role in regulation of insulin and glucagon secre- 
tion in islet of Langerhans in an autocrine or paracrine 
manner. 
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